The following guideline on the Management of Newly Diagnosed Type 2 Diabetes Mellitus in Children and Adolescents was developed by the American Academy of Pediatrics, and endorsed with qualifications by the AAFP. This guideline was developed to provide evidence-based recommendations on managing 10- to 18-year old patients in whom T2DM has been diagnosed.
Clinical Preventive Services Recommendation
For Your Patients
The American Academy of Pediatrics’ Committee suggests that clinicians encourage children and adolescents with T2DM to engage in moderate-to-vigorous exercise for at least 60 minutes daily and to limit nonacademic screen time to less than 2 hours per day.
The reasons for the AAFP's endorsement with qualifications are as follows:
The following guideline on the Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus was developed by the American College of Physicians and endorsed by the AAFP.
These guidelines are provided only as assistance for physicians making clinical decisions regarding the care of their patients. As such, they cannot substitute the individual judgment brought to each clinical situation by the patient’s family physician. As with all clinical reference resources, they reflect the best understanding of the science of medicine at the time of publication, but they should be used with the clear understanding that continued research may result in new knowledge and recommendations. These guidelines are only one element in the complex process of improving the health of America. To be effective, the guidelines must be implemented.
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.
Diabetes -- Clinical Practice Guidelines